Valcyte 450 mg, 60 tablets (Valganciclovir 450 mg) by Roche.
Indications: CMV retinitis in AIDS patients; prevention of CMV disease in CMV-negative recipients of solid organ transplants from CMV-positive donors.
Administration: Oral with food; induction 900 mg twice daily, maintenance 900 mg once daily.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Valganciclovir 450 mg (as hydrochloride) per tablet — antiviral. |
| Strength & pack | 60 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |